Muyang Li

Oncology · Nature · 2002–2007

A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom Muyang Li trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. C. Sherr
  2. Bert Vogelstein

Who trusts Muyang Li overall

  1. C. Brooks
  2. W. Gu
  3. Ann M. Bode
  4. J. Kruse

Papers from Muyang Li's perspective

Ordered by how strongly the researchers Muyang Li trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The ARF/p53 pathway. (Current Opinion in Genetics and Development)
  2. Regulation of the Cdk inhibitor p27 and its deregulation in cancer (Journal of Cellular Physiology)
  3. The Myc/Max/Mad network and the transcriptional control of cell behavior. (Annual Review of Cell and Developmental Biology)
  4. Genomic targets of the human c-Myc protein. (Genes & Development)
  5. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas (Nature)
  6. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. (Cell)
  7. Anticancer drugs: To the rescue? (Nature reviews. Drug discovery)
  8. Surfing the p53 network (Nature)
  9. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. (Cell)
  10. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. (Cell)

Their papers